CAR-T safety monitoring
Integrating viral vector-based cell and gene therapies carry a potential risk of secondary cancers, prompting the FDA to require 15 years of post-marketing follow-up for CAR-T therapies.
PAXgene RNA extraction
TATAA Biocenter’s optimized protocol enables high-quality RNA extraction from PAXgene® blood RNA tubes, delivering improved RNA integrity and yield for both clinical and preclinical applications.
Guide to PCR in drug development
A comprehensive guide to qPCR, dPCR, and Two-Tailed PCR for regulated and exploratory applications in drug development.
Vector copy number analysis in CAR-T development
Precise VCN quantification in CAR-T therapy, enabling safe dosing, persistence monitoring, and regulatory compliance.
siRNA bioanalysis with qPCR, dPCR, and NGS
Sensitive and precise siRNA bioanalysis with qPCR, dPCR, NGS, and Two-Tailed PCR technology.
GLP-1 receptor agonists therapeutics
Mechanisms, therapeutic applications, and future directions in precision medicine for GLP-1 receptor agonists.
Overview of bioanalysis in advanced therapies
- Assay design and validation
- Regulatory guidelines (EMA and FDA)
- Challenges and best practices
Genomic biomarker analysis (DNA, RNA, miRNA, ctDNA etc,)
- Technology overview
- Analytical validation
- Regulatory overview
TATAA capabilities brochure
Download our latest brochure for an overview of our molecular CRO expertise in CGT bioanalysis, biomarker analysis, and assay development.
Advancing Vaccine Research with Illumina Protein Prep
Discover our recent application note on advancing vaccine research with one of the most comprehensive protein profiling panels available.
